Withi
Within the newest buying and selling session, DexCom (DXCM) closed at $209.50, marking a +1.58% transfer from yesterday. This transfer outpaced the S&P 500’s every day lack of 4.34%. Elsewhere, the Dow misplaced 4.55%, whereas the tech-heavy Nasdaq misplaced 3.79%.
Previous to as we speak’s buying and selling, shares of the medical gadget firm had misplaced 31.82% over the previous month. This has lagged the Medical sector’s lack of 22.08% and the S&P 500’s lack of 28.78% in that point.
DXCM might be seeking to show energy because it nears its subsequent earnings launch. On that day, DXCM is projected to report earnings of $0.11 per share, which might symbolize year-over-year progress of 320%. In the meantime, the Zacks Consensus Estimate for income is projecting web gross sales of $357.53 million, up 27.46% from the year-ago interval.
For the complete 12 months, our Zacks Consensus Estimates are projecting earnings of $2.25 per share and income of $1.78 billion, which might symbolize adjustments of +22.28% and +20.32%, respectively, from the prior 12 months.
…